Fanconi anemia gene mutations are not involved in sporadic Wilms tumor
Bi-allelic germline mutations of the Fanconi anemia (FA) genes, PALB2/FANCN and BRCA2/FANCD1, have been reported in a few Wilms tumor (WT) patients with an atypical FA phenotype. Therefore, we screened a random cohort of 47 Dutch WT cases for germline mutations in these two FA-genes by DNA sequencing and Multiplex Ligation-dependent Probe Amplification (MLPA). Although several cases appeared to carry missense variants, no bi-allelic pathogenic mutations were identified, indicating that bi-allelic mutations in these FA-genes do not contribute significantly to the occurrence of WT. Pediatr Blood Cancer.
|Keywords||BRCA2/FANCD1, Fanconi anemia, PALB2/FANCN, Wilms tumor|
|Persistent URL||dx.doi.org/10.1002/pbc.22588, hdl.handle.net/1765/28568|
Adank, M.A., Segers, H., van Mil, S.E., van Helsdingen, Y.M., Ameziane, N., van den Ouweland, A.M.W., … van den Heuvel-Eibrink, M.M.. (2010). Fanconi anemia gene mutations are not involved in sporadic Wilms tumor. Pediatric Blood & Cancer, 55(4), 742–744. doi:10.1002/pbc.22588